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Abstract
Background: Allograft bone used in joint replacement surgery can additionally serve as a carrier for antibiotics and 
serve as a prophylaxis against infections. However, in vitro dose-response curves for bone chips impregnated with 
different kinds of antibiotics are not available. In addition, while it would be desirable to add the antibiotics to allograft 
bone chips before these are stored in a bone bank, the effects of different storage temperatures on antibiotics are 
unknown.
Methods: Five different antibiotics (cefazolin, clindamycin, linezolid, oxacillin, vancomycin) were stored, both as pills 
and as solutions, at -80°C, -20°C, 4°C, 20°C and 37°C; in addition, bone chips impregnated with cefazolin and 
vancomycin were stored at -80°C and -20°C. After 1 month, 6 months and 1 year, the activity of the antibiotics against 
Staphylococcus epidermidis was measured using an inoculated agar. The diameter of the S. epidermidis-free zone was 
taken as a measure of antibiotic activity.
In a separate experiment, in vitro dose-response curves were established for bone chips impregnated with cefazolin
and vancomycin solutions at five different concentrations.
Finally, the maximum absorbed amounts of cefazolin and vancomycin were established by impregnating 1 g of bone
chips with 5 ml of antibiotic solution.
Results: A decrease of the S. epidermidis-free zone was seen with oxacillin and cefazolin solutions stored at 37°C for 1 
month, with vancomycin stored at 37°C for 6 months and with cefazolin and oxacillin solutions stored at 20°C for 6 
months. The activity of the other antibiotic solutions, pills and impregnated bone chips was not affected by storage. 
The in vitro dose-response curves show that the free-zone diameter increases logarithmically with antibiotic 
concentration. The absorbed antibiotic amount of one gram bone chips was determined.
Conclusions: Storage of antibiotics in frozen form or storage of antibiotic pills at temperatures up to 37°C for 12 
months does not affect their activity. However, storage of antibiotic solutions at temperatures above 20°C does affect 
the activity of some of the antibiotics investigated. The in vitro dose-response curve can be used to determine the 
optimal concentration(s) for local application. It provides the opportunity to determine the antibiotic content of bone 
chips, and thus the amount of antibiotics available locally after application.
Background
Infection is one of the most devastating adverse events
following joint replacement surgery. Deep infection rates
in primary hip replacement surgery are around 0.5% to
2%. These infections result in a reduced quality of life
[1,2]. The patient often needs several re-operations, and if
surgical debridement is not sufficient a Girdlestone situa-
tion is created; the patient then has to function without
prosthesis for three to six months, which markedly limits
physical activity. Furthermore, the hospitalisation costs
for an infected patient are about 3.7 times those for a sim-
ilar, uninfected patient [1].
Bone impaction grafting (BIG) for joint replacement
surgery has been used with satisfactory results in clinical
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practice, for acetabular reconstructions since 1979 and
for femoral reconstructions since 1987 [3-10]. With BIG,
first the segmental bone defects in acetabulum and femur
are restored with metal meshes. Next, these defects are
filled with tightly impacted morselized cancellous bone
chips in combination with a cemented prosthesis. Osteo-
clasts will resorb necrotic graft remnants and osteoblasts
will form new woven bone. This remodelling of newly
formed bone into its characteristic structure will lead to
the biological repair of the defect following surgery [11].
Surgery with BIG is more complex and time-consum-
ing than primary hip surgery which may contribute to a
higher infection rate in hip revision surgery (percentages
ranging from 2.0% to 2.5% [12-14]). BIG creates an avas-
cular area where local circulation is disrupted. If infec-
tions arises, this may prevent antibiotics that are
administered systemically to reach the infected bone [15].
In addition, the formation of a biofilm on the surface of
the implant renders systemic antibiotics less effective
[16].
Bone cements containing antibiotics were developed to
solve this problem. These cements may serve as a drug
delivery system and prophylaxis against infections as they
make it possible to achieve higher local drug concentra-
tions. However, controversy exists on the efficacy of the
antibiotic-containing cements [17]. Probably 90% of the
antibiotics contained in the cement is never released [18].
Only when cracks are formed in the cement layer will a
small, sub-inhibitory amount of antibiotics be released
into the surrounding tissue. This release can continue for
years, potentially inducing resistance [18].
Several studies have shown that morselized allograft
bone, which is used not only in BIG but also in other sur-
geries, can be made to act as a carrier for antibiotics,
either by impregnating the bone grafts with various anti-
biotic solutions [19-22,22,23], or by mixing them with
antibiotic powders [24,25]. Although these studies
showed, in vitro as well as in vivo, that bone impregnated
with antibiotics can be used effectively as prophylaxis
against infections, they did not establish the concentra-
tion of antibiotic present in the bone after impregnation
and how much was released locally. Furthermore, no cor-
relation of antibiotic concentration and zone of inhibition
was reported of the antibiotics used in combination with
bone chips. Finally, allograft bone is stored at a bone bank
at -80°C, then thawed in the operating room. In the
impregnation studies, all the antibiotics were added to
the thawed bone, immediately before use. It is thus
unknown whether the antibiotics can be added before
freezing without affecting their activity.
Based on this we investigated if storage of antibiotics
and antibiotic-loaded bone grafts at different tempera-
tures affects their activity. The correlation between anti-
biotic concentration and zones of inhibition for the bone/
antibiotics composites was analysed. The results permit
us to develop a standardized bone bank product in which
the amount of antibiotics present on the bone chips, and
therefore the amount of antibiotics released locally from
the bone, will be known.
Methods
Measurement of activities
For all tests performed in this study, the following
method was used:
Antibiotic pills, antimicrobial susceptibility test disks
(Oxoid) with antibiotic solution dripped onto the disks
and bone chips impregnated with antibiotic solution were
placed on an inoculated iso agar (cefazolin, clindamycin,
linezolid or vancomycin) or an inoculated Mueller Hin-
ton agar (oxacillin). Bone chips were placed in a hole of 10
mm diameter punched into, but not through, the agar
and then covered with 25 μl saline dripped onto them.
All agars were inoculated with 0.5 McFarland ATCC
12228 Staphylococcus epidermidis since this organism is
one of the main pathogens colonizing biomaterials [26].
After storing the iso agars at 37°C and the Mueller Hinton
agars at 30°C for 18-24 hours, the zones of inhibition
were measured.
Antibiotic pills from the routine clinical lab were used
as controls. The zone of inhibition of these pills is compa-
rable to that of 10 μl antibiotic solution and that of chips
freshly impregnated with 10 μl antibiotic solution.
Cefazolin, clindamycin, linezolid, oxacillin and vanco-
mycin were used in this study, all antibiotics against gram
stain positive micro-organisms, the main cause for ortho-
paedic infections. Oxacillin is the preferred treatment for
systemic staphylococcal infections and in case of penicil-
lin hypersensitivity the others are used (mainly cefazolin
or clindamycin). For prophylaxis cefazolin or clindamycin
are preferred and in case of infection with methicillin
resistant Staphylococcus aureus (MRSA) vancomycin is
used. In this way all important antibiotics against these
gram stain positive micro-organisms were tested. The
concentrations used for the tests are the concentrations
used in the whole range of clinical situations: systemic or
local infection and prophylactic use. In addition, high
concentrations were used to determine local concentra-
tion limits.
Five different storage temperatures were used in the
experiments. -80°C and -20°C are storage temperatures
for allograft bone in bone banks. 4°C and 20°C are com-
monly used storage temperatures in the laboratory and
20°C is the temperature of the operation room. 37°C was
included so as to investigate antibiotic stability at higher
temperature and because this temperature is body tem-
perature.
Mathijssen et al. BMC Musculoskeletal Disorders 2010, 11:96
http://www.biomedcentral.com/1471-2474/11/96
Page 3 of 9
Storage of antibiotic pills
Pills of five different antibiotics - cefazolin 60 μg, clin-
damycin 25 μg, linezolid 30 μg, oxacillin 1 μg and vanco-
mycin 70 μg - were stored at five different temperatures.
For each antibiotic, nine pills of each antibiotic were
stored in a closed tube at each temperature. After 1
month, 6 months and 1 year of storage, three pills of each
antibiotic were brought to room temperature and placed
on an agar to determine the inhibition zone of the pills.
Storage of antibiotic solutions
Five different antibiotic solutions - cefazolin 6.0 mg/ml,
clindamycin 2.5 mg/ml, linezolid 3.0 mg/ml, oxacillin 0.1
mg/ml and vancomycin 7.0 mg/ml - were stored at five
different temperatures. For each antibiotic solutions, 9
tubes of 1 ml, were stored at each temperature. After 1
month, 6 months and 1 year of storage, three tubes of
each antibiotic solution were brought to room tempera-
ture and 0.10 μg of each antibiotic solution was dripped
onto a antimicrobial susceptibility test disk which was
then placed on an agar.
Storage of bone chips impregnated with antibiotic 
solutions
60 tubes, each containing 0.10 g of bone chips from a
human morselized femoral head, were impregnated with
60 μg/10 μl cefazolin solution for ten minutes, then 30
were stored at -80°C and 30 at -20°C. Similarly, 60 tubes
with 0.10 g bone chips each were impregnated with 70
μg/10 μl vancomycin and 30 were stored at -80°C and 30
at -20°C. Other storage temperatures were not tested,
since bone allografts cannot be used for transplantation
after storage at temperatures above -20°C for more than
one month. After 1 month and 6 months of storage, 20
tubes each of the cefazolin- and the vancomycin-impreg-
nated bone chips (ten tubes from -80°C and 10 tubes
from -20°C storage) were thawed and placed on iso agars
(figure 1).
Correlation of antibiotic concentration and zone of 
inhibition of bone impregnated with vancomycin and 
cefazolin
Five different cefazolin solutions and five different vanco-
mycin solutions were used to impregnate bone chips
from a morselized femoral head and to determine the
correlation of antibiotic concentration and zone of inhibi-
tion. The concentrations were chosen so as to exceed the
minimal inhibitory concentration, and similar to that of
the control pills from the clinical routine lab (cefazolin 60
μg and vancomycin 70 μg). Cefazolin: 0.5 μg/10 μl, 2.5 μg/
10 μl, 10 μg/10 μl, 60 μg/10 μl and 100 μg/10 μl; vancomy-
cin: 0.5 μg/10 μl, 2.5 μg/10 μl, 10 μg/10 μl, 70 μg/10 μl and
100 μg/10 μl. For each concentration, ten 0.10 g bone
chips were impregnated at room temperature for ten
minutes and placed on agar as described above; the mean
diameter of the free zone was measured, and the antibi-
otic quantity was correlated to the zone of inhibition.
Determination of the maximum amount of antibiotics 
absorbed by bone chips
One gram of bone chips from a morselized femoral head
was impregnated with 5 ml of cefazolin or vancomycin
solution. The maximum absorbed amount was then cal-
culated based on the correlation between antibiotic con-
centration and zone of inhibition determined earlier.
Chips were impregnated with four different cefazolin
solutions (1000 μg/5 ml, 750 μg/5 ml, 500 μg/5 ml and
250 μg/5 ml) and with four different vancomycin solu-
tions (5000 μg/5 ml, 2500 μg/5 ml, 1000 μg/5 ml and 250
μg/5 ml). After ten minutes of impregnation the remain-
ing solution was poured off. 0.10 gram was taken off the
impregnated 1 gram and placed on an inoculated agar;
this was repeated five times. The zone of inhibition
around the chips was measured. Matching this zone to a
zone of inhibition in the correlation analysis performed
earlier yielded the matching amount of antibiotics and
thus the maximum amount of antibiotic that can be
absorbed at this concentration. In a repeat test, after the
antibiotic solution was poured off the bone chips were
rinsed twice with 5.0 ml saline in order to remove any
antibiotic solution remaining on the surface of the bone
chips; thus, the real amount absorbed by the bone chips
was calculated.
Results
Storage of antibiotics
No differences were seen, compared to controls, in the
zone of inhibition for cefazolin, vancomycin, linezolid
Figure 1 Bone chips on an inoculated iso agar.
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and clindamycin pills that had been stored at -80°C, -
20°C, 4°C, 20°C and 37°C for 1 month, 6 months and 1
year. Also, no differences in response at any of these tem-
peratures were found for clindamycin and linezolid solu-
tions that had been stored for 12 months.
Oxacillin pills stored at 4°C for 12 months showed a
decreased zone of inhibition compared to controls. Oxa-
cillin solutions showed a decreased zones of inhibition
after 1 month of storage at 37°C and after 6 months of
storage at 20°C. No zone of inhibition could be found
after 12 months of storage at 20°C and after 6 months of
storage at 37°C (figure 2). At other temperatures, no dif-
ferences in the zone of inhibition were seen compared to
controls.
Vancomycin solutions stored at 37°C for 6 months
showed a decreased zone of inhibition, while the zone of
inhibition was not affected after 1 month of storage at
this temperature (figure 3). At -80°C, -20°C and 4°C no
differences were visible compared to controls as was the
case for vancomycin solutions stored at 20°C for 6
months; however, 12 months at 20°C did result in a
decreased zone of inhibition (figure 3).
For cefazolin solutions, the zone of inhibition was
decreased when compared to controls after storage at
37°C for 1 month and at 20°C for 6 and 12 months. No
zone of inhibition could be seen after 6 and 12 months of
storage at 37°C (figure 3).
Storage of bone chips impregnated with antibiotics
Bone chips impregnated with vancomycin or cefazolin,
stored at -20°C and -80°C for 6 months did not show a
difference in zone of inhibition when compared to con-
trols (figure 4)
Correlation of antibiotic concentration and zone of 
inhibition of bone chips impregnated with vancomycin and 
cefazolin
The correlation of antibiotic quantity and zone of inhibi-
tion of bone chips impregnated with cefazolin and vanco-
mycin is presented in figure 5. A curve was fitted between
the quantity of antibiotic and diameter of inhibition zone
measured. With increasing antibiotic quantity, the zone
of inhibition increases logarithmically.
Determination of the maximum absorbed amount
Table 1 represents the results of the impregnating bone
chips with 5 ml cefazolin or vancomycin solution. The
zones of inhibition of 0.10 g bone chips impregnated with
5 ml antibiotic solution (and rinsed with saline twice) are
related to antibiotic quantity in figure 5 (represented by
the squares). The associated quantity of antibiotic present
Figure 2 Storage of oxacillin pills at 4°C and oxacillin solutions at 20°C and 37°C compared to controls. Storage of oxacillin pills (1 μg) at 4°C 
and oxacillin solutions (0.1 mg/ml) at 20°C and 37°C for 1 month, 6 months and 12 months compared to controls.
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in 0.10 g of chips can then be read from the figure, and
from this, the antibiotic content of 1.0 g bone chips is
determined (table 1).
Discussion
Storage of antibiotics
The effects of different storage temperatures on antibiot-
ics were studied. In addition, we examined the reaction to
freezing of bone chips impregnated with antibiotics. It
can be concluded that storage at -80°C and -20°C does
not affect the activity of antibiotics for 1 year, and that, of
bone chips impregnated with cefazolin and vancomycin
up to 6 months. This shows that bone chips can be
impregnated with antibiotics before storage in a bone
bank. This makes surgery easier, safer and less time-con-
suming for the orthopaedic surgeon since they do not
have to add the antibiotics during the procedure and
faults can be avoided this way.
Correlation of antibiotic quantity and zone of inhibition of 
bone impregnated with vancomycin and cefazolin and 
determination of the maximum absorbed amount
Numerous studies have concluded that morselized bone
can act as a carrier for antibiotics [19-22,22-25]. These
studies show that prophylactic use of bone chips impreg-
nated with antibiotics can be effective. However, the
amount of antibiotics present in the bone chips after
impregnation was not determined in any of these studies,
while antibiotics are effective only if their concentration
is high enough to eradicate bacteria. Our study investi-
gated the reactions, in vitro, of S. epidermidis to bone
chips impregnated with cefazolin and vancomycin solu-
tions. Correlation of antibiotic quantity and zone of inhi-
bition of bone chips impregnated with the antibiotic
solutions show that increasing amounts of cefazolin and
vancomycin increase the zone of S. epidermidis inhibition
logarithmically. At therapeutic concentrations, the corre-
lation analysis is a good reproduction of reality, even
though the zones of inhibition at high concentrations are
probably not very reliable. The question can be asked
whether it is necessary to use the maximum local
amounts of antibiotics obtainable. It is apparent from fig-
ure 5 that increasing the antibiotic amount to above
approximately 20 μg per 0.1 gram bone chips will not sig-
nificantly increase the zone of inhibition. This suggests
that approximately 20 μg per 0.1 gram bone chips is suffi-
cient to eradicate the bacteria in vitro.
Local antibiotic therapy has to meet several other
requirements in addition to that of sufficient concentra-
tion at the site of infection. Drug delivery has to be con-
Figure 3 Storage of vancomycin and cefazolin solutions at 20°C and 37°C compared to controls. Storage of cefazolin solutions (6.0 mg/ml) and 
vancomycin solutions (7.0 mg/ml) at 20°C and 37°C for 1 month, 6 months and 12 months compared to controls.
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trolled in order to ensure that known adverse drug effects
like deafness or renal failure are prevented [22]. Also,
antibiotic concentrations should not be cytotoxic to
osteoblasts or bone tissue. According to Edin, Miclau et
al. [27], local levels of vancomycin of < 1000 μg/ml do not
affect osteoblast replication. Cefazolin at concentrations
of 200 μg/ml decreases cell replication, but does not
affect the replication of osteoblasts at levels of 100 μg/ml.
The concentrations of cefazolin and vancomycin solu-
tions in our study were neither toxic to osteoblasts nor
able to cause systemic side effects, but were very effective
against S. epidermidis in vitro. However, the concentra-
tions needed in prophylaxis against infections might be
different.
To our knowledge, no studies have investigated how
long high local antibiotic concentrations must be sus-
tained to obtain effective infection prophylaxis. The pro-
longed release of antibiotics from antibiotic-containing
bone cement did not protect against late hematogenous
infections[28]. For prevention, a high local antibiotic con-
centration will be effective, even if this is only for a short
time; one or two days, or even a few hours, can be suffi-
cient. As long as the concentration of vancomycin and
cefazolin is above the minimal inhibitory concentration
(MIC) for S. epidermidis, it will have the maximum effect.
The concentrations used in this study are well above
MIC; taking into account the half-life of these antibiotics,
they will stay above MIC - and be effective - for at least 8
to 10 hours. For therapeutic use, the carrier may be more
effective if the antibiotic concentration is high for a lon-
ger period, preferably for 2-4 weeks. The diffusion of the
antibiotic into the infected tissues takes time, as does the
killing process of the bacteria.
Witso et al. [22] have shown that the elution profile
from bone chips is different for different antibiotics. The
elution profile of cephalosporins (cefazolin) shows a high
initial release with rapid decay. After three days, all the
antibiotics are eluted from the bone chips, leaving no
subinhibitory amount of drug that could induce resis-
tance. Therefore, cefazolin is a good choice for local pro-
phylaxis. However, cephalosporins carry a small risk of
hypersensitivity[29]. Vancomycin is another good choice
for impregnating bone chips; it has low resistance and
allergy rate and, like cefazolin, is very effective against S.
epidermidis and Staphylococcus. aureus, the main patho-
gens colonizing biomaterials[26]. The elution profile of
vancomycin is not as steep as that of cefazolin, with some
elution even after seven days.
Figure 4 Storage of bone chips impregnated with cefazolin and vancomycin solutions for 1 month and 6 months at -20°C and -80°C, com-
pared to controls. Storage of cefazolin solutions (6.0 mg/ml) and vancomycin solutions (7.0 mg/ml) at -80°C and -20°C for 1 month and 6 months 
compared to controls.
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From past experience, it is likely that it will only be a
matter of time before bacteria develop a mechanism of
resistance against any new locally applied antibiotic.
Therefore, further research into the use of combinations
of antibiotics, i.e. multidrug targeting, is in order[30].
Differences between rinsing with saline and not rinsing
the bone chips after impregnation were also studied. We
hypothesized that rinsing the bone chips would remove
antibiotic solution remaining on the surface of the chips.
With cefazolin, bone chips rinsed with saline twice had a
smaller free zone than bone chips that were not rinsed.
This difference was not found with vancomycin. The
activity of the antibiotics against S. epidermidis was still
evident after rinsing the bone chips with saline, and high
enough to eradicate the bacteria. It can therefore be con-
cluded that the antibiotics are absorbed by the bone chips
and the activity does not stem from antibiotic solution
remaining on the surface of the bone chips. In vivo
research is needed to assess the clinical value of antibiot-
ics-impregnated bone chips.
Conclusions
In conclusion, storage at -80°C and -20°C of antibiotic
solutions, antibiotic pills and bone chips impregnated
with cefazolin and vancomycin does not affect the activ-
ity of the drugs for at least one year. It is therefore possi-
ble to impregnate bone chips with antibiotics and store
them in a bone bank at one of these temperatures. Also,
storage of antibiotic pills at temperatures up to 37°C for
12 months does not affect their activity. However, storage
of antibiotic solutions at temperatures above 20°C does
affect the activity of some of the antibiotics investigated.
Based on the correlation of antibiotic quantity and zone
of inhibition for cefazolin and vancomycin, optimal con-
centration(s) for impregnation of bone chips were deter-
mined. The correlation provides the opportunity to
determine the antibiotic content of the bone chips so that
a safe and reproducible bone bank product can be devel-
oped.
Figure 5 Regression analysis of bone chips impregnated with antibiotic solutions. Squares represent the inhibition zones for 0.10 g of bone 
chips taken from 1.0 g of bone chips impregnated with 5 ml of antibiotic solution and rinsed with saline twice; the fitted curves yield the correspond-
ing antibiotic content.
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Table 1: Impregnation of bone chips with cefazolin and vancomycin solutions
Antibiotic Rinsing with 0.9% 
saline, +/-
Antibiotic content of 
impregnation fluid
(μg/5 ml)
Mean diameter of 
S. epidermidis-free zone 
(mm)
Mean antibiotic content 
of 1.0 g of bone chips
(μg)
Cefazolin + 1000 28.0 ± 1.2 32
+ 750 23.6 ± 1.3 15
+ 500 23.0 ± 1.2 13
+ 250 19.6 ± 0.5 7
- 1000 32.4 ± 0.9 105
- 750 31.8 ± 0.8 92
- 500 29.0 ± 2.4 44
- 250 28.6 ± 0.5 39
Vancomycin + 5000 23.2 ± 0.5 214
+ 2500 22.0 ± 1.0 212
+ 1000 17.8 ± 1.1 204
+ 250 7.6 ± 6.9 178
- 5000 24.2 ± 0.8 215
- 2500 23.6 ± 1.1 214
- 1000 22.8 ± 3.3 212
- 250 16.0 ± 0.7 201
Antibiotic quantity of 1.0 g bone chips, with and without rinsing of the bone chips, is calculated using the regression analysis of the antibiotic 
solution (figure 5).
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